Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression
Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression
Not yet recruiting · NCT07199010 · Registry updated 2025-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression | Non-small Lung Cancer | Not yet recruiting | Not stated | 2025-09-30 | NCT07199010 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innovent Biologics (Suzhou) Co. Ltd. | 82 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai East Hospital (The East Hospital Affiliated to Tongji University) | Shanghai | China | 1 |